ABSTRAL

LOE Approaching

fentanyl citrate

NDASUBLINGUALTABLET
Approved
Jan 2011
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4

Mechanism of Action

analgesia. Other members of the class known as opioid agonists include substances such as morphine, oxycodone, hydromorphone, codeine, and hydrocodone.

Clinical Trials (4)

NCT01315886Phase 4Terminated

Conversion From Fast Acting Oral Opioids to Abstral®

Started Feb 2011
NCT00343733Phase 3Completed

Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain

Started Aug 2006
120 enrolled
Pain
NCT00214942Phase 3Completed

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain

Started Sep 2005
Chronic Low Back Pain
NCT00214955Phase 3Completed

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

Started Sep 2005
120 enrolled
Chronic Neuropathic Pain